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A 34-year-old woman presented with recurrent attacks
of breathlessness and seizures. The patient’s condition
worsened during the course of her hospital stay, as a
result of which she had to be intubated twice.
Radiological studies showed a mass in the trachea and
the subsequent biopsy of the mass revealed an
inﬁltrating carcinoma with morphological features of
adenoid cystic carcinoma.
BACKGROUND
Neoplasms of the trachea with the trachea as
primary origin are extremely rare, they occur in
every 2.6 per one million people per year.1
Malignant tumours comprise of 86% of all primary
tracheal tumours, the most common of which are
squamous cell carcinomas, followed by adenoid
cystic carcinomas. Anatomically, adenoid cystic car-
cinomas originate from the submucosal glands that
are embedded in the epithelial lining of the
trachea.2 Conventionally, adenoid cystic carcinomas
are slow growing tumours that metastasise haema-
togenously and by direct extension through the
submucosa. Metastatic spread to the lymph nodes
is uncommon.3 Surgery followed by radiation has
shown to have the best outcome. Early detection of
the disease, followed by surgical resection of the
tumour with regular follow-ups is imperative for
securing a good prognosis.4
CASE PRESENTATION
A 34-year-old woman presented to the emergency
department, with a 1- day history of shortness of
breath, fever and two episodes of unresponsiveness.
She reported having a 2-month history of episodic,
sudden shortness of breath at rest, along with the
twitching of facial muscles, jerking of the limbs and
up rolling of the eyes, followed by loss of con-
sciousness. She also reported faecal and urine
incontinence during these episodes. She was placed
on non-invasive ventilation due to hypoxaemia,
and was treated as having a case of acute asthma
exacerbation with salbutamol and ipratropium
bromide nebulisation, along with fluticasone and
salmeterol inhaler. She was given lamotrigine,
phenytoin and valproic acid for her seizures. She
was treated with clarithromycin and ceftriaxone for
a possible infection. The antibiotics were stopped
when negative blood and urine cultures were
obtained.
The patient was diagnosed with asthma a year
prior to her presentation, based on spirometry,
which showed a forced vital capacity (FVC) of
63%, forced expiratory volume in 1 s (FEV1) of
43% and FEV1/FVC ratio of 67%. Her condition
was being monitored by a general practitioner in
her village. Two months prior to admission, she
had reported having at least 15 episodes of ﬁts,
each of which was followed by asthma exacerba-
tion. The patient’s EEG and MRI were normal; she
was prescribed lamotrigine, phenytoin and valproic
acid to control her seizures. For her asthma, she
was given intravenous methylprednisone, albuterol
inhaler, fluticasone and montelukast; however, her
condition did not improve.
A physical examination revealed a young woman
in no respiratory distress. She was alert and respon-
sive. Vital signs revealed a body mass index of
27.6 kg/m2, blood pressure 170/110 mm Hg, pulse
144 bpm, respiratory rate 36/min, O2 saturation of
98% and temperature 37.6°C. Chest examination
revealed bilateral harsh vesicular breath sounds
with an audible wheeze. Motor examination
revealed a power of 3/5 in all four limbs. Mild
bilateral pitting oedema was noted in both legs.
INVESTIGATIONS
Complete blood cell count showed a white cell
count of 16.9 with neutrophils of 91.7%. Arterial
blood gas showed pH of 7.34, pCO2 of 74.10,
pO2 of 213.30 (on supplemental oxygen), bicar-
bonate of 40.60 and oxygen saturation of 99.70%
(on bi-level positive airway pressure). The patient’s
blood and urine cultures were both negative. Chest
X-ray showed no signiﬁcant abnormality (ﬁgure 1).
DIFFERENTIAL DIAGNOSIS
A diagnosis of acute asthma exacerbation, hypercar-
bic respiratory failure and complex partial seizures
Figure 1 Normal chest X-ray, no signiﬁcant
abnormality is seen.
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was made. The patient was treated with a combination of ster-
oids, bronchodilators and antibiotics, along with non-invasive
ventilation. She was weaned off the non-invasive ventilation and
did well for a day. The next day, she developed respiratory dis-
tress, hypoxia and a low Glasgow Coma Scale. The arterial
blood gases showed pH of 7.12, pCO2 of 51.9, pO2 of 126,
bicarbonate of 41.3 and oxygen saturation of 69%. She was
intubated and shifted to the intensive care unit. The Neurology
consult team advised optimisation of the antiepileptics. She
remained stable on the ventilator, and hence she was
re-extubated the next day. She was re-intubated, secondary to
hypercarbia, within 2 h of extubation.
Contrast-enhanced CT of the chest and neck showed an inﬁl-
trating oval-shaped soft tissue mass arising from the right lateral
wall of the trachea, which was causing signiﬁcant narrowing of
the tracheal lumen; no evidence of metastatic disease was seen
(ﬁgure 2).
Bronchoscopy revealed a mass impinging on the trachea and
its surrounding structures.
TREATMENT
The patient underwent a right posterior lateral thoracotomy,
with tracheal mass biopsy and tracheostomy. The operative ﬁnd-
ings conﬁrmed a large ﬁrm mass, adherent to the trachea
externally, with signiﬁcant impingement. The mass was deemed
to be non-resectable. Histopathology revealed an inﬁltrating
carcinoma with the morphological features of adenoid cystic
carcinoma (ﬁgure 3). Two mediastinal lymph nodes were also
found to be malignant.
OUTCOME AND FOLLOW-UP
The patient was treated with palliative radiation therapy to the
mediastinum. At 6-month follow-up, the patient reported to be
doing well.
DISCUSSION
Tracheal tumours comprise of 1–2% of all lung masses, and
hence have a low incidence.5 These tumours may either be
benign or malignant in nature. Benign tracheal tumours such as
lipomas, hamartomas and neurolemmomas are rare. However,
malignant tumours such as squamous cell carcinomas and
adenoid cystic carcinomas comprise 80% and 16.3% of all tra-
cheal tumours in adults, respectively.6 These tumours usually
present with asthma-like symptoms—due to the impinging of
the tumour on the surrounding organs.
An adenoid cystic carcinoma is a rare tumour of unknown
aetiology. The tumour has a predilection to grow on several dif-
ferent sites of the body, such as the head and neck region, the
breast and the pelvis. Previously, this tumour of the tracheobron-
chial tree variety was referred to as a cylindroma, due to the
cylindrical shape of epithelial cells of mucous glands.7 It occurs
most commonly in the ﬁfth and sixth decades of life, and is not
predisposed to a particular gender. Symptomatically, the tumour
closely resembles asthma—with cough and dyspnoea being
prominent manifestations of the disease.8 One of the atypical
symptoms in our case were recurrent seizures. We found only
one study that reported a 13% incidence of seizures in patients
with cancer, mainly due to intracranial metastasis, strokes, antic-
ancer medication or metabolic disturbances.9 However, the
patient’s brain imaging studies were clear and serum electrolytes
were normal, hence ruling out a metabolic disturbance.
Postresection the tumour has a high rate of local recurrence,
most likely due to the perineural invasion of the tumour.10
Metastasis most commonly occurs to the bones and lungs, and
is usually characteristic of a late stage of disease.
Surgical resection and reconstruction remain the mainstay of
treatment. Radiotherapy may be offered as a form of palliative
therapy, or it may be offered postoperatively in cases where the
tumour is not resectable, or in cases where metastasis of the
disease has occurred.11 Chemotherapy with carboplatinum and
paclitaxel, in conjunction with radiotherapy, has shown to be
successful in some trials.12
Learning points
▸ A high index of suspicion is required to diagnose tracheal
tumours.
▸ Tracheal tumours must be considered as an alternate
diagnosis in cases where a patient does not respond to
asthma treatment.
▸ Not all ‘wheezes’ are asthma.
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Figure 2 Soft tissue mass, 35×19 mm, located 15 mm above the
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